On Feb. 2, Histogenics Corporation (NASDAQ:HSGX) announced the appointment of David Gill to its board of directors and chairman of the audit committee. Mr. Gill is currently the Chief Financial Officer of EndoChoice, Inc., a medical device company which provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal (GI) diseases. On Monday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $8.35.
On Feb 04, Coherus Biosciences, Inc. (NASDAQ:CHRS) announced that it will participate in a fireside chat at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11 at 1:50 pm ET in New York City. Coherus Biosciences, Inc. (NASDAQ:CHRS) in last trading activity moved up 12.91% to close at $32.36. Company weekly performance is 43.89%. Coherus Biosciences, Inc. (NASDAQ:CHRS) is 10.07% away from its 52 week high.
On last trading day Derma Sciences Inc. (NASDAQ:DSCI) fell -2.00% to close at $8.82. Its volatility for the week is 4.01% while volatility for the month is 4.97%. DSCI’s sales growth for past 5 years was 9.70% and its EPS growth for past 5 years was -11.30%. Derma Sciences Inc. (NASDAQ:DSCI) monthly performance is -4.75%.
On Feb 02, VeriFone Systems, Inc. (NYSE: PAY) said it will release its fiscal first quarter 2015 financial results after the market closes on March 10, 2015. VeriFone Systems, Inc. (NYSE:PAY) has 0.30% insider ownership while its institutional ownership stands at 94.60%. In last trading activity company’s stock closed at $32.69.
Ameris Bancorp (NASDAQ:ABCB) on Jan 29, reported fourth-quarter net income of $10.6 million. The bank, based in Moultrie, Georgia, said it had earnings of 39 cents per share. On last trading day Ameris Bancorp (NASDAQ:ABCB) fell -1.18% to close at $25.16. Its volatility for the week is 2.87% while volatility for the month is 3.72%. ABCB’s sales growth for past 5 years was 7.50% and its EPS growth for past 5 years was 19.60%. Ameris Bancorp (NASDAQ:ABCB) monthly performance is 1.86%.